Progression of vascular depression to possible vascular dementia

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 22, Issue 4, 2010, Pages

  Loganathan, Santosh ^a   Phutane, Vivek H ^b   Prakash, Om ^c   Varghese, Mathew ^d  

^a VYDEHI INSTITUTE OF MEDICAL SCIENCES AND RESEARCH CENTRE   (India)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

^d NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; AMLODIPINE; ATORVASTATIN; CLOPIDOGREL; DONEPEZIL; ESCITALOPRAM; LOSARTAN; MIRTAZAPINE; NIMODIPINE; NORTRIPTYLINE; PRAMIPEXOLE; QUETIAPINE; TRAZODONE;

ADULT; ANOREXIA; BEDTIME DOSAGE; CASE REPORT; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HOPELESSNESS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LETTER; MEMORY DISORDER; MENTAL HEALTH; MOOD DISORDER; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECALL; TASTE DISORDER; TREATMENT RESPONSE; VASCULAR DEPRESSION; WAKEFULNESS; WEAKNESS; WORKING MEMORY; BRAIN CORTEX; CAROTID ARTERY DISEASE; MIDDLE AGED; PATHOLOGY;

CAROTID ARTERY DISEASES; CEREBRAL CORTEX; CORONARY ARTERY DISEASE; DEMENTIA, VASCULAR; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 78149305173     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.22.4.451-t.e34     Document Type: Letter

References (8)

1. Alexopoulos GS, Meyers BS, Young RC, et al: Vascular depression hypothesis. Arch Gen Psychiatry 1997; 54:915-922
2. Barnes DE, Alexopoulos GS, Lopez OL, et al: Depressive symptoms, vascular disease, and mild cognitive impairment findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006; 63:273-280
3. Jorm AF: History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry 2001; 35:776-781
4. Krishnan KR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997; 154:497-501
5. Sneed JR, Rindskopf D, Steffens, DC, et al: The vascular depression subtype: evidence of internal validity. Biol Psychiatry 2008; 64:491-497
6. Steffens DC, Taylor WD, Krishnan KRR: Progression of subcortical ischemic disease from vascular depression to vascular dementia. Am J Psychiatry 2003; 160:1751-1756
7. Taragano FE, Allegri R, Vicarioet A, et al: A double blind randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of vascular depression. Int J Geriatr Psychiatry 2001; 16:254-260
8. Black S, Román GC, Geldmacher DS, et al: Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 2003; 34:2323-2332